Your very own pharmacist just a click (and consult) away
Consumers are working more, playing more, shopping more and learning more online than ever before. So the click-and-consult services that Rite Aid has made available to its wellness+ members not only represent today’s cutting edge, but also offer a peek into how consumers may interact with their healthcare teams tomorrow.
“Patients take a great deal of interest in being able to have a conversation with their pharmacist,” said Robert Thompson, Rite Aid EVP pharmacy. “The online chat is just another vehicle by which a patient might be able to have a discussion with a Rite Aid pharmacist,” he said. And that’s important, Thompson added, because each means of communication holds relevance for different groups of the population. And whether a patient prefers one-on-one consultations, round-the-clock telephone access—an 800 number for wellness+ members to consult a Rite Aid pharmacist has been up and running since that program’s inception in April—or this new online portal, Rite Aid has made itself available to its patients no matter a patient’s personal consultation preference. “For us, it’s all about providing a service that will enhance the ability of patients to communicate with a pharmacist,” Thompson added.
As for the service, wellness+ members can avail themselves of a pharmacist consultation at any time, day or night, either online or in select stores. “The pharmacists that staff our clinical call center are all PharmDs,” Thompson noted. “And many of them have received additional forms of clinical training. Our clinical call center does a variety of clinical programs—including supporting chat—that are really focused on compliance initiatives. They also provide clinical support for our own pharmacists internally.”
Rite Aid’s team of clinical pharmacists will be available to counsel patients on such issues as potential drug-drug interactions between their prescription therapies and their nonprescription remedies, or what foods and drinks may interfere with the effectiveness of their therapies. The clinical pharmacists also will be prepared to counsel on general health questions, such as how to control high blood pressure or lower cholesterol; how to tell the difference between a cold and the flu; ways to help manage diabetes; how to deal with insomnia; and questions about vaccinations.
The Apothecary Shops earns spot on Inc.’s fastest-growing private companies list
PHOENIX Diplomat Specialty Pharmacy isn’t the only one to earn a spot on Inc. magazine’s list of the fastest-growing private companies.
The Inc. 5000 also listed specialty pharmacy The Apothecary Shops, ranking 2,394. That marked a jump of 322 spots from last year and 1,682 spots from 2008 in its fourth annual appearance on the list.
Drug Store News reported Thursday on Diplomat’s inclusion on the list.
“It’s no secret that we have undertaken a very aggressive growth strategy for The Apothecary Shops, but our approach, particularly in a down economy, has been targeted and strategic to be in a solid position to leverage that growth when the economy turns,” The Apothecary Shops president Keith Cook said. “Our movement on the Inc. 5000 list of fastest-growing companies reflects the success of our strategic direction.”
Type 2 diabetes linked with cognitive impairments, study shows
WASHINGTON A small study conducted by Canadian researchers found factors that may link Type 2 diabetes with such cognitive impairments as dementia.
Older adults with diabetes who also have high blood pressure, walk slowly or lose their balance, or believe they’re in bad health, are more likely to have poorer cognitive functions than those without these problems, according to a new study conducted by researchers at the University of Alberta in Canada and published in the September issue of Neuropsychology
The study of older Canadians — 41 adults with Type 2 diabetes, ages 55 to 81 years, and 458 matched healthy controls (ages 53 to 90 years) — found that systolic blood pressure, a low combination score for gait and balance, and a patient’s own reports of poor health all played a statistically significant role in the relationship between diabetes and cognitive impairment.
“Awareness of the link between diabetes and cognition could help people realize how important it is to manage this disease, and to motivate them to do so,” said co-author Roger Dixon, PhD, of the University of Alberta.
Type 2 diabetes has been found by other researchers to nearly double the risk of dementia and Alzheimer’s disease, said Dixon, who studies how health affects cognition in aging. As diabetes becomes more common, this heightened risk could dramatically hike the number of older people with dementia.
The prevalence of diabetes in the United States for people older than age 60 — according to the National Institute of Diabetes and Digestive and Kidney Diseases — is more than 23%, while Canadian prevalence is nearly 19%, according to the Public Health Agency of Canada.